Quarterly ResultJun 3, 2026, 06:51 AM
Medtronic FY26 Revenue Up 8.4% to $36.4B; Q4 EPS $1.55
AI Summary
Medtronic plc reported strong financial results for its fourth quarter and full fiscal year 2026, marking the highest annual revenue growth in 10 years. The company announced Q4 revenue of $9.8 billion, up 9.9% as reported and 6.6% organically, with full-year revenue at $36.4 billion, up 8.4% as reported and 5.8% organically. Key growth drivers included the Cardiovascular and Medical Surgical portfolios, with notable strength in Cardiac Ablation Solutions. Medtronic also declared its 49th consecutive annual dividend increase. The company provided guidance for FY27, expecting organic revenue growth of 6.75% to 7.25% and non-GAAP diluted EPS between $5.90 and $6.00.
Key Highlights
- Medtronic reported Q4 FY26 revenue of $9.8 billion, up 9.9% as reported and 6.6% organically.
- FY26 revenue reached $36.4 billion, an increase of 8.4% as reported and 5.8% organically.
- Q4 non-GAAP diluted EPS was $1.55, ahead of guidance.
- FY26 non-GAAP diluted EPS was $5.53, an increase of 0.7%.
- Cardiac Ablation Solutions revenue increased 78% globally in Q4.
- Cardiovascular portfolio revenue grew 10.1% in Q4.
- Medical Surgical portfolio revenue increased 5.1% in Q4.
- Medtronic announced a 49th consecutive annual dividend increase to $0.72 per share for Q1 FY27.
Price Impact
More from MDT